3-year LIFE-BTK results in 261 patients with infrapopliteal CLTI: drug-eluting resorbable scaffold vs angioplasty had higher Kaplan-Meier primary efficacy (59.5% vs 44.8%; P=0.0025) with comparable safety (90.8% vs 94.2%); only 57% completed follow-up.
RCTn = 261
Parikh et al. Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial